Gencurix, a leading provider of cancer molecular diagnostics, announced the release of clinical research results directly comparing the accuracy of its breast cancer prognostic test, GenesWell BCT, with Oncotype DX, the globally top-selling test, confirming its outstanding performance.
VITRAC Therapeutics, LLC presented a poster on the Phase 1a/1b clinical trial of aurora kinase A inhibitor, VIC-1911, as monotherapy and in combination with KRAS G12C inhibitor, sotorasib.
LOTTE BIOLOGICS, under the leadership of CEO Richard Lee, enthusiastically disclosed its participation in the upcoming ‘BIO International Convention 2023’ to be held from June 5th to June 8th, 2023, at the illustrious Boston Convention & Exhibition Center, USA.
Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announced that new data will be presented on TG4001.
SCG Cell Therapy Pte Ltd presented late-breaking data from its first-in-class autologous HBsAg-specific T-Cell receptor-engineered T Cell Therapy – SCG101 – at the International Society for Cell & Gene Therapy conference in Paris, France.
Biophytis SA announces it will participate at the Biotechnology Innovation Organization International Convention to be held in Boston from the 5th to the 8th of June 2023, alongside thousands of world leaders in biotechnology and the pharmaceutical industry.
Ascentage Pharma announced that it has released updated clinical results of olverembatinib, a third-generation tyrosine kinase inhibitor, in patients with TKI-resistant succinate dehydrogenase -deficient gastrointestinal stromal tumor, in a Poster Presentation at the 59th American Society of Clinical Oncology Annual Meeting.
En el contexto del cambio climático y la necesidad de reducir las emisiones de gases de efecto invernadero, es crucial evaluar las distintas opciones energéticas y su impacto ambiental. En este artículo, exploraremos y compararemos la quema de madera y la quema de combustibles f …
Desde tiempos inmemoriales, los seres humanos han sentido curiosidad por la posibilidad de comunicarse con otras especies inteligentes en nuestro planeta. En particular, los delfines y las ballenas, conocidos por su alta inteligencia y sofisticados sistemas de comunicación, han despertado un …
Drugs that act on the CFTR protein only work in patients who produce the protein in the first place. That leaves 6% of patients hanging.
ReCode, Vertex and 4DMT Seek to Help Yet Untreated Cystic Fibrosis Patients Read More »
